Intellia Therapeutics
Martyna Pawlikowska, MBA, currently serves as the Manager of Regulatory Project Management at Intellia Therapeutics, Inc., a position held since February 2023. Prior experience includes a tenure at AbbVie from May 2014 to February 2023, where roles encompassed Project Coordinator II in Discovery, Scientist I for Antibody Drug Conjugates, Associate Scientist II for Antibody Drug Conjugates, and Project Support in Process Development Purification. Martyna also contributed as an Undergraduate Researcher at Providence College from November 2014 to June 2015. Martyna holds an MBA from Boston University (2023), a Master's degree in Biotechnology from Worcester State University (2019), a Bachelor's degree in Biotechnology from Worcester State University (2018), and a Bachelor's degree in Biology from Providence College (2015).
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.